This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ suxibuzone,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Anti-inflammatory Properties: Suxibuzone belongs to the class of NSAIDs, which work by inhibiting the enzyme cyclooxygenase (COX), thereby reducing the production of prostaglandins, which are substances involved in inflammation, pain, and fever. By decreasing inflammation, suxibuzone can alleviate pain and swelling associated with various conditions in horses.

  2. Equine Use: Suxibuzone is primarily indicated for the treatment of musculoskeletal disorders and inflammatory conditions in horses, including osteoarthritis, laminitis, and soft tissue injuries. It is commonly prescribed by veterinarians to manage pain and inflammation in horses involved in athletic activities or suffering from chronic joint problems.

  3. Analgesic Effects: In addition to its anti-inflammatory properties, suxibuzone also possesses analgesic (pain-relieving) effects, which can help alleviate discomfort and improve the mobility and quality of life of affected horses.

  4. Oral Administration: Suxibuzone is typically administered orally, either as tablets, granules, or paste formulations. The dosage and duration of treatment depend on the specific condition being treated, the severity of symptoms, and the individual horse's response to therapy.

  5. Side Effects: Like other NSAIDs, suxibuzone may cause adverse effects in horses, including gastrointestinal ulceration, renal toxicity, and hepatotoxicity. Long-term use or administration at high doses may increase the risk of these adverse effects. It is essential for horse owners and caretakers to closely monitor for signs of gastrointestinal upset (e.g., colic, diarrhea), changes in appetite, or other unusual symptoms during suxibuzone therapy.

  6. Veterinary Guidance: Suxibuzone should only be used in horses under the supervision and guidance of a veterinarian. Before initiating treatment, the veterinarian will perform a thorough examination to assess the horse's condition and determine the most appropriate treatment plan, which may include suxibuzone alone or in combination with other therapies.

  7. Alternatives: In some cases, alternative medications or therapies may be considered for the management of pain and inflammation in horses, particularly if there are concerns about the potential side effects of NSAIDs like suxibuzone. These alternatives may include other NSAIDs, corticosteroids, joint supplements, physical therapy, and rest.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of suxibuzone,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Anaerobutyricum hallii Reduces
species Bacteroides uniformis Reduces
species Bifidobacterium adolescentis Reduces
species Blautia hansenii Reduces
species Christensenella minuta Reduces
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces
species Lactococcus cremoris Reduces
species Streptococcus thermophilus Reduces

Bacteria Impacted by suxibuzone,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Ruminococcus genus Decreases
0 1 Escherichia genus Decreases
1 0 Akkermansia genus Decreases
0 1 Coprococcus genus Decreases
0 1 Enterocloster genus Decreases
0 1 Streptococcus genus Decreases
0 1 Lachnospira genus Decreases
0 1 Shigella genus Decreases
0 1 Bacteroides genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 1 Wujia genus Decreases
0 1 Vescimonas genus Decreases
0 1 Bifidobacterium genus Decreases
0 1 Clostridium genus Decreases
0 1 Fusobacterium genus Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Escherichia coli species Decreases
1 0 Ruminococcus bromii species Decreases
1 0 Streptococcus salivarius species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Coprococcus comes species Decreases
1 0 Mediterraneibacter gnavus species Decreases
1 0 Bacteroides ovatus species Decreases
1 0 Enterocloster bolteae species Decreases
1 0 Lachnospira eligens species Decreases
1 0 Bacteroides fragilis species Decreases
0 1 Shigella dysenteriae species Decreases
0 1 Shigella flexneri species Decreases
0 1 Escherichia albertii species Decreases
0 1 Streptococcus sp. FDAARGOS_192 species Decreases
0 1 Escherichia fergusonii species Decreases
1 0 Bacteroides uniformis species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
0 1 Shigella boydii species Decreases
0 1 Blautia argi species Decreases
1 0 Bacteroides xylanisolvens species Decreases
0 1 Anaerobutyricum hallii species Decreases
0 1 Enterocloster clostridioformis species Decreases
0 1 Coprococcus catus species Decreases
0 1 Blautia sp. SC05B48 species Decreases
0 1 Dorea longicatena species Decreases
0 1 Shigella sonnei species Decreases
0 1 Butyrivibrio crossotus species Decreases
0 1 Fannyhessea vaginae species Decreases
0 1 Komagataeibacter oboediens species Decreases
0 1 Dorea formicigenerans species Decreases
0 1 Flavonifractor plautii species Decreases
0 1 Escherichia marmotae species Decreases
0 1 Blautia obeum species Decreases
0 1 Streptococcus sp. LPB0220 species Decreases
0 1 Streptococcus sp. HSISM1 species Decreases
0 1 Hungatella hathewayi species Decreases
0 1 Blautia parvula species Decreases
0 1 Escherichia sp. E4742 species Decreases
0 1 Bacteroides sp. D2 species Decreases
0 1 Wansuia hejianensis species Decreases
0 1 Coprococcus eutactus species Decreases
0 1 Ligilactobacillus ruminis species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Eubacterium sp. MSJ-33 species Decreases
0 1 Lachnoanaerobaculum gingivalis species Decreases
0 1 [Ruminococcus] lactaris species Decreases
0 1 Blautia liquoris species Decreases
0 1 Eubacterium ventriosum species Decreases
0 1 Bacteroides sp. DH3716P species Decreases
0 1 Clostridium sp. M62/1 species Decreases
0 1 Roseburia hominis species Decreases
0 1 Streptococcus vestibularis species Decreases
0 1 Faecalitalea cylindroides species Decreases
0 1 Lacrimispora saccharolytica species Decreases
0 1 Clostridium sp. SY8519 species Decreases
0 1 Bacteroides sp. M10 species Decreases
0 1 Coprococcus sp. ART55/1 species Decreases
0 1 Wujia chipingensis species Decreases
0 1 Faecalibacterium duncaniae species Decreases
0 1 Novisyntrophococcus fermenticellae species Decreases
0 1 Eubacterium limosum species Decreases
1 0 Bifidobacterium adolescentis species Decreases
1 0 Clostridium perfringens species Decreases
0 1 Christensenella minuta species Decreases
0 1 Qiania dongpingensis species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Ruminococcus albus species Decreases
1 0 Streptococcus parasanguinis species Decreases
0 1 Vescimonas fastidiosa species Decreases
0 1 Faecalibacterium sp. I4-1-79 species Decreases
0 1 Catenibacterium sp. co_0103 species Decreases
0 1 Eubacterium maltosivorans species Decreases
0 1 Maliibacterium massiliense species Decreases
0 1 Pseudobutyrivibrio xylanivorans species Decreases
0 1 Butyrivibrio fibrisolvens species Decreases
0 1 Roseburia rectibacter species Decreases
0 1 Eubacterium callanderi species Decreases
0 1 Anaerostipes caccae species Decreases
0 1 Olsenella sp. oral taxon 807 species Decreases
0 1 Catenibacterium mitsuokai species Decreases
0 1 Faecalibacterium sp. HTF-F species Decreases
0 1 Faecalibacterium sp. I2-3-92 species Decreases
0 1 Ruminococcus champanellensis species Decreases
0 1 Simiaoa sunii species Decreases
0 1 Ruthenibacterium lactatiformans species Decreases
0 1 Anaerostipes hadrus species Decreases
0 1 Treponema peruense species Decreases
0 1 Massilistercora timonensis species Decreases
0 1 Faecalibacterium sp. IP-3-29 species Decreases
0 1 Faecalibacillus intestinalis species Decreases
0 1 Clostridium cadaveris species Decreases
0 1 Blautia hansenii species Decreases
0 1 Phoenicibacter congonensis species Decreases
0 1 Ruminococcus bicirculans (ex Wegman et al. 2014) species Decreases
0 1 Faecalibacterium sp. IP-1-18 species Decreases
0 1 Actinomyces naeslundii species Decreases
0 1 Roseburia intestinalis species Decreases
0 1 Lactococcus cremoris species Decreases
0 1 Intestinibaculum porci species Decreases
0 1 Lachnoclostridium phocaeense species Decreases
0 1 Faecalibacterium sp. I3-3-33 species Decreases
0 1 Marvinbryantia formatexigens species Decreases
0 1 Faecalibacterium sp. I3-3-89 species Decreases
0 1 [Clostridium] hylemonae species Decreases
0 1 Blautia producta species Decreases
0 1 Longicatena caecimuris species Decreases
0 1 Vescimonas coprocola species Decreases
0 1 Streptococcus thermophilus species Decreases
0 1 Streptococcus suis species Decreases
0 1 Bacteroides sp. A1C1 species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
1 0 [Ruminococcus] torques species Decreases
1 0 Fusobacterium nucleatum species Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases
0 1 Fusobacterium nucleatum subsp. nucleatum subspecies Decreases

Impact of suxibuzone,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.1 -0.1
ADHD 1.7 0.6 1.83
Age-Related Macular Degeneration and Glaucoma 0.1 0.1
Allergic Rhinitis (Hay Fever) 1.6 1.6 0
Allergies 2.9 2.3 0.26
Allergy to milk products 2.1 0.7 2
Alopecia (Hair Loss) 0.1 -0.1
Alzheimer's disease 3.7 2.8 0.32
Amyotrophic lateral sclerosis (ALS) Motor Neuron 2.7 1.7 0.59
Ankylosing spondylitis 2.3 1.4 0.64
Anorexia Nervosa 0.8 1.6 -1
Antiphospholipid syndrome (APS) 1 1
Asthma 2.5 1.5 0.67
Atherosclerosis 1.7 0.5 2.4
Atrial fibrillation 1.9 0.8 1.37
Autism 4.7 4.8 -0.02
Autoimmune Disease 0.8 0.1 7
Barrett esophagus cancer 0 0.3 0
benign prostatic hyperplasia 0.5 0.2 1.5
Biofilm 1.6 1.6
Bipolar Disorder 1.1 0.7 0.57
Brain Trauma 0.3 0.6 -1
Breast Cancer 0.7 0.7
Cancer (General) 0 0.6 0
Carcinoma 1.3 0.6 1.17
Celiac Disease 1.6 1.2 0.33
Cerebral Palsy 0.9 0.6 0.5
Chronic Fatigue Syndrome 4.6 2.6 0.77
Chronic Kidney Disease 1.5 1.2 0.25
Chronic Lyme 0.2 -0.2
Chronic Obstructive Pulmonary Disease (COPD) 2.1 0.8 1.63
Chronic Urticaria (Hives) 1.3 1 0.3
Coagulation / Micro clot triggering bacteria 1.4 0.6 1.33
Cognitive Function 0.9 0.4 1.25
Colorectal Cancer 4.4 1.1 3
Constipation 1.3 1.3
Coronary artery disease 2.5 1.1 1.27
COVID-19 4.4 6.6 -0.5
Crohn's Disease 4.3 3.2 0.34
Cushing's Syndrome (hypercortisolism) 0.2 -0.2
cystic fibrosis 0.9 0.4 1.25
d-lactic acidosis (one form of brain fog) 0.6 0.6
deep vein thrombosis 2.2 0.8 1.75
Denture Wearers Oral Shifts 0.9 0.9
Depression 5.2 4.3 0.21
Dermatomyositis 0.3 0.1 2
Eczema 1.4 1.5 -0.07
Endometriosis 1.9 1.6 0.19
Eosinophilic Esophagitis 0 0.3 0
Epilepsy 2.6 1.1 1.36
erectile dysfunction 0.8 0.1 7
Fibromyalgia 0.5 1.1 -1.2
Functional constipation / chronic idiopathic constipation 3.7 1.5 1.47
gallstone disease (gsd) 2.4 0.4 5
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.5 0.9 -0.8
Generalized anxiety disorder 2.8 1.2 1.33
giant cell arteritis 0.1 -0.1
Glioblastoma 0.3 -0.3
Gout 1.3 0.9 0.44
Graves' disease 0.6 0.9 -0.5
Gulf War Syndrome 0.6 1.4 -1.33
Halitosis 0.5 0.3 0.67
Hashimoto's thyroiditis 1.7 0.9 0.89
Heart Failure 3.5 0.9 2.89
hemorrhagic stroke 0 0
Hidradenitis Suppurativa 0.7 0.7
High Histamine/low DAO 0.8 0.4 1
hypercholesterolemia (High Cholesterol) 0.7 0.6 0.17
hyperglycemia 1.9 1.1 0.73
Hyperlipidemia (High Blood Fats) 0.4 0.4
hypertension (High Blood Pressure 2.7 2.7 0
Hypothyroidism 0.3 0.4 -0.33
Hypoxia 0.7 0.7
IgA nephropathy (IgAN) 0.9 2.3 -1.56
Inflammatory Bowel Disease 5.1 5 0.02
Insomnia 1.5 2 -0.33
Intelligence 1.5 1.5
Intracranial aneurysms 0.6 0.4 0.5
Irritable Bowel Syndrome 3.6 3.2 0.13
ischemic stroke 1.5 0.7 1.14
Liver Cirrhosis 3.7 2.9 0.28
Long COVID 3.8 3.2 0.19
Low bone mineral density 0.7 -0.7
Lung Cancer 0.5 1.2 -1.4
Lymphoma 0.5 0.5
Mast Cell Issues / mastitis 0.8 0.7 0.14
ME/CFS with IBS 1 1.6 -0.6
ME/CFS without IBS 1.1 0.6 0.83
membranous nephropathy 0.3 0.3
Menopause 1.1 0.4 1.75
Metabolic Syndrome 3.9 3.3 0.18
Mood Disorders 5.5 3.7 0.49
multiple chemical sensitivity [MCS] 1.3 1.3
Multiple Sclerosis 3.4 2.6 0.31
Multiple system atrophy (MSA) 1.1 0.4 1.75
myasthenia gravis 0.8 0.1 7
neuropathic pain 0.9 -0.9
Neuropathy (all types) 0.6 0.3 1
neuropsychiatric disorders (PANDAS, PANS) 0.9 0.9
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 3 2.5 0.2
NonCeliac Gluten Sensitivity 0.8 0.2 3
Obesity 5 5 0
obsessive-compulsive disorder 3.9 2.1 0.86
Osteoarthritis 1.9 1.3 0.46
Osteoporosis 1.1 1 0.1
pancreatic cancer 0.3 0.3 0
Parkinson's Disease 5.3 2.9 0.83
Polycystic ovary syndrome 3.5 1.8 0.94
Postural orthostatic tachycardia syndrome 0.1 0.4 -3
Premenstrual dysphoric disorder 0.1 0.1
primary biliary cholangitis 0.3 0.6 -1
Primary sclerosing cholangitis 0.6 1.7 -1.83
Psoriasis 2.3 1.1 1.09
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 3.6 1.1 2.27
Rosacea 0.7 0.1 6
Schizophrenia 2.9 1.5 0.93
scoliosis 1.1 0.9 0.22
sensorineural hearing loss 0.3 0.3
Sjögren syndrome 0.8 0.6 0.33
Sleep Apnea 1.1 0.5 1.2
Slow gastric motility / Gastroparesis 1.2 0.1 11
Small Intestinal Bacterial Overgrowth (SIBO) 1.5 1.5
Stress / posttraumatic stress disorder 1.5 1.1 0.36
Systemic Lupus Erythematosus 2.3 0.8 1.87
Tic Disorder 0.6 0.3 1
Tourette syndrome 0.6 0.2 2
Type 1 Diabetes 3.3 1.5 1.2
Type 2 Diabetes 4.5 3.7 0.22
Ulcerative colitis 2.7 3.5 -0.3
Unhealthy Ageing 2.6 0.7 2.71
Vitiligo 1.6 1 0.6

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]